The dose is gradually increased over several weeks to minimise gastrointestinal side effects, starting at 2.5 mg and potentially escalating to a maximum maintenance dose of 15 mg, with each dose increase occurring after at least 4 weeks if tolerated
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Polysaccharides including Cycloartenol-ferulic acid glycoside, Diferulic acid complex, Diferulic acid-calcium complex, Hemicelluloses, Arabinogalactan, Arabinoxylan, Xyloglucan, Proteoglycan, Glycoprotein, Arabinofuranoside
Such models might help identify promising design motifs and module assemblies for defined TME phenotypes [109]
Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease